COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Announcement on Resolutions of the 30th Meeting of the Fourth Board of Directors of Jilin Zixin Pharmaceutical Co., Ltd.

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-010

Jilin Zixin Pharmaceutical Co., Ltd.

Announcement on Resolutions of the 30th Meeting of the Fourth Board

 

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

 

The 30th meeting of the 4th Board of Directors of Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as the “Company”) was held on the spot on April 01, 2013 by means of a voting method on the spot. The meeting was notified by telephone on March 20, 2013. E-mails, etc. are issued in accordance with the provisions of the Company Law and the Articles of Association. The meeting should attend 7 directors and actually attend 7 directors. The convening of this meeting is in line with the relevant provisions of the Company Law and the Articles of Association. The convening procedures and voting results of this meeting are legal and valid.

The meeting was held in the conference room of the company and was presided over by Mr. Cao Enhui, the chairman of the board of directors. Mr. Guo Chunsheng, director of the board of directors, Ms. Li Fei, independent director, and Mr. Fang Yong participated in the voting method. After careful consideration by the attending directors, the following proposals were considered and approved:

I. The “Proposal on Approving the Holding Company's Jilin Zixin Red Stone Breeding Co., Ltd. to apply for working capital loans from Jilin Branch Co., Ltd. Tonghua Branch” was reviewed and approved.

The result of the review: 7 votes in favor, 0 votes against, and 0 abstentions.

Agree to the subsidiary Jilin Zixin Red Stone Breeding Co., Ltd. to apply for a working capital loan of no more than RMB 200 million to the Tonghua Branch of Jilin Bank Co., Ltd., to supplement the working capital, and the loan term is three years.

2. The “Proposal on Providing Guarantee for the Holding Subsidiary Jilin Zixin Red Stone Breeding Co., Ltd.” was reviewed and approved.

The result of the review: 7 votes in favor, 0 votes against, and 0 abstentions.

It is agreed that the company will provide joint and several liability guarantees for the holding subsidiary of Jilin Zixin Red Stone Breeding Co., Ltd. to the Tonghua Branch of Jilin Bank Co., Ltd. for the loan of RMB 200 million. The guarantee period is the loan with Jilin Zixin Red Stone Breeding Co., Ltd. Two years from the expiration of the debt performance period agreed in the contract. This guarantee shall be submitted to the company's shareholders meeting for deliberation, and the shareholders' meeting shall be convened at a later date. For details, please refer to the “Announcement on Providing Guarantees for Holding Subsidiaries” of the Company (2013-011).

Special announcement

Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors

April 2, 2013